InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Becoming a substantial holder 1 Jul 2020 4:20PM $0.061 $0.010 fallen by 83.61%
- Lapse of Employee Share Options 1 Jul 2020 11:52AM $0.061 $0.010 fallen by 83.61%
- Appendix 2A 30 Jun 2020 3:40PM $0.055 $0.010 fallen by 81.82%
- Cleansing Notice 30 Jun 2020 3:08PM $0.056 $0.010 fallen by 82.14%
- Executive Chairman - New Consultancy Agreement 22 Jun 2020 10:04AM $0.069 $0.010 fallen by 85.51%
- Proposed issue of Securities - BNO 2 Jun 2020 11:13AM $0.057 $0.010 fallen by 82.46%
- Recapitalisation Led by Apeiron Investment Group Ltd 2 Jun 2020 9:41AM $0.048 $0.010 fallen by 79.17%
- BNO Extends Cash Runway Through Deferral of Loan Repayments 11 May 2020 9:58AM $0.044 $0.010 fallen by 77.27%
- Appendix 4C - quarterly 23 Apr 2020 1:21PM $0.049 $0.010 fallen by 79.59%
- Recruitment Completed in Phase 2 BNC105 / Nivolumab Trial 15 Apr 2020 10:34AM $0.054 $0.010 fallen by 81.48%
- Published BNC210 Phase 2b Data, Additional Information 3 Apr 2020 9:59AM $0.040 $0.010 fallen by 75%
- Positive Phase 2b Data for BNC210 in GAD Patients Published 2 Apr 2020 9:57AM $0.035 $0.010 fallen by 71.43%
- Completion of Sale of Bionomics' French Subsidiaries 3 Mar 2020 9:46AM $0.044 $0.010 fallen by 77.27%
- Half Yearly Report and Accounts 28 Feb 2020 1:36PM $0.045 $0.010 fallen by 77.78%
- Appendix 4C - quarterly 30 Jan 2020 2:05PM $0.072 $0.010 fallen by 86.01%
- Bionomics Corporate Presentation 29 Jan 2020 10:52AM $0.071 $0.010 fallen by 85.92%
- Lapse of Unlisted Employee Share Options and Warrant 19 Dec 2019 11:13AM $0.083 $0.010 fallen by 87.95%
- Sale of French Subsidiaries to Domain Therapeutics 11 Dec 2019 10:33AM $0.090 $0.010 fallen by 88.89%
- Results of Meeting 20 Nov 2019 2:10PM $0.100 $0.010 fallen by 90%
- Planned Recruitment of New CEO 20 Nov 2019 11:34AM $0.100 $0.010 fallen by 90%
- Executive Chairman's 2019 AGM Presentation 20 Nov 2019 11:27AM $0.100 $0.010 fallen by 90%
- Bionomics Receives R&D Tax Incentive Refund of $5.1M 11 Nov 2019 11:52AM $0.115 $0.010 fallen by 91.30%
- FDA Grants Fast Track Designation to BNC210 PTSD Program 4 Nov 2019 10:02AM $0.094 $0.010 fallen by 89.36%
- Appendix 4C - quarterly 28 Oct 2019 10:23AM $0.094 $0.010 fallen by 89.36%
- Appendix 4G / Corporate Governance Statement 18 Oct 2019 12:55PM $0.108 $0.010 fallen by 90.70%

251 - 275 of 801 results

Page 11 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.